Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Expenditures: 2015-2025

Historic Capital Expenditures for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to $248,000.

  • Wave Life Sciences' Capital Expenditures fell 35.25% to $248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $805,000, marking a year-over-year decrease of 33.36%. This contributed to the annual value of $938,000 for FY2024, which is 15.87% down from last year.
  • Latest data reveals that Wave Life Sciences reported Capital Expenditures of $248,000 as of Q3 2025, which was down 18.95% from $306,000 recorded in Q2 2025.
  • Over the past 5 years, Wave Life Sciences' Capital Expenditures peaked at $492,000 during Q2 2022, and registered a low of $15,000 during Q4 2021.
  • Moreover, its 3-year median value for Capital Expenditures was $248,000 (2025), whereas its average is $252,000.
  • Per our database at Business Quant, Wave Life Sciences' Capital Expenditures crashed by 97.31% in 2021 and then surged by 1,260.00% in 2022.
  • Wave Life Sciences' Capital Expenditures (Quarterly) stood at $15,000 in 2021, then spiked by 1,260.00% to $204,000 in 2022, then surged by 74.51% to $356,000 in 2023, then plummeted by 75.84% to $86,000 in 2024, then crashed by 35.25% to $248,000 in 2025.
  • Its Capital Expenditures stands at $248,000 for Q3 2025, versus $306,000 for Q2 2025 and $165,000 for Q1 2025.